What is Skybiotech Healthcare Ltd (512036) share price return in the past 10 years?

Skybiotech Healthcare Ltd share price has declined -0.4% annually (CAGR) over the past ten years.

What is the share price of Skybiotech Healthcare Ltd (512036)?

Company share prices are keep on changing according to the market conditions. The current trading price of Skybiotech Healthcare Ltd (512036) on 17-Apr-2026 16:59:59 at 16:59 is 138.90.

What is the P/E ratio of Skybiotech Healthcare?

The latest standalone P/E ratio of Skybiotech Healthcare as of 17-Apr-2026 is 0.00.

What is the P/B ratio of Skybiotech Healthcare Ltd (512036)?

The latest standalone P/B ratio of Skybiotech Healthcare Ltd (512036) as of 17-Apr-2026 is 2.28.

What is the 52-week high and low of Skybiotech Healthcare Ltd (512036)?

The 52-week high of Skybiotech Healthcare Ltd (512036) is Rs. 237.30 and the 52-week low is Rs. 116.45.

Skybiotech Healthcare Ltd (512036) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Skybiotech Healthcare Ltd (512036)
Brand: Skybiotech Healthcare

Skybiotech Healthcare Ltd (512036) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹27 Cr.

P/E Ratio

0.00

Price to Book (P/B)

2.28

Price to Sales (P/S)

0.00

EV/EBITDA

-86.33

Return on Capital Employed (ROCE)

0.67%

Current Price

₹138.9

Return on Equity (ROE)

0.53%

Return on Assets (ROA)

0.49%

Operating Profit Margin

Net Profit Margin

INF%

Gross Profit Margin

Book Value per Share

₹61

Sales Growth (YoY)

NA%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-96.1%

52-Week Low / High

₹116 / 237

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

63.48%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Skybiotech Healthcare Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -0.4% based on the current price.

Q.1 Which industry/sub-sector does Skybiotech Healthcare Ltd belong to?

Skybiotech Healthcare Ltd belongs to the Textiles & Apparels sector, operating specifically within the Textile segment.

Q.1 Debt to Equity ratio of Skybiotech Healthcare Ltd?

Skybiotech Healthcare Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.17, indicating lower debt levels in the industry.

Q.1 Promoter shareholding and pledge status of Skybiotech Healthcare Ltd?

Promoters hold 63.48% of the Skybiotech Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Skybiotech Healthcare Ltd vs industry peers?

Skybiotech Healthcare Ltd revenue CAGR is %, compared to the industry median CAGR of 12.68%, indicating slower growth and losing its market share.

DeciZen - make an informed investing decision on Skybiotech Healthcar

Based on:

Data

M-Cap below 100cr DeciZen not available

Skybiotech Healthcare stock performance

Key Ratios

Is Skybiotech Healthcare Ltd an attractive stock to invest in?

1. Is Skybiotech Healthcare Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Skybiotech Healthcare Ltd is a below average quality company.

2. Is Skybiotech Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Skybiotech Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Skybiotech Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Skybiotech Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.3%	1%	-0.1%	-1%	-1.5%	-1.8%	-1.1%	-0.2%	26.2%	0.7%	-
Value Creation Index ⓘ	-1.0	-0.9	-1.0	-1.1	-1.1	-1.1	-1.1	-1.0	0.9	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Adj EPS ⓘ	0.2	0.2	-0	-0.2	-0.6	-0.5	-0.3	-0.2	1.2	-0.2	-1.4
YoY Gr.	-	-23.8%	-125%	NA	NA	NA	NA	NA	NA	-113.6%	-
BVPS (₹) ⓘ	17.2	24.2	26.4	27.2	21.6	30.9	35.8	33.6	56.6	61.5	61
Adj Net Profit ⓘ	0	0	-0	-0	-0.1	-0.1	-0	-0	0.2	-0	-0
Cash Flow from Ops. ⓘ	-0	0	0	0.1	-0.6	1.3	0.6	-0.4	-1.3	0.3	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	-197%	NA	NA	-113.6%
BVPSⓘ	15.2%	23.3%	19.8%	8.8%
Share Price	-0.4%	47.3%	23.4%	-31.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.2	0.8	-0.2	-0.6	-2.3	-1.8	-1	-0.6	3.1	-0.3	-2.3
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	-INF
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-1.4	-9.9
TTM Sales (₹ Cr.)	0	6.3
BVPS (₹) ⓘ	61	43
Reserves (₹ Cr.) ⓘ	10	6
P/BV ⓘ	2.28	3.23
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	116.45 / 237.30
All Time Low / High (₹)	19.05 / 350.80
Market Cap (₹ Cr.)	26.6
Equity (₹ Cr.)	1.9
Face Value (₹)	10
Industry PE ⓘ	33.9

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Skybiotech Healthcar - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ +	0.08	0.20	0.06	0.06	0.10	0.07	0.06	0.06	0.13	0.10
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0.03	0.08	0.02	0	0.01	0.02	0.01	0.01	0.01	0.01
Other Costs ⓘ	0.05	0.12	0.04	0.06	0.09	0.05	0.05	0.05	0.11	0.09
Operating Profit ⓘ	-0.08	-0.20	-0.06	-0.06	-0.10	-0.07	-0.06	-0.06	-0.13	-0.10
Operating Profit Margin (%)	-	-	-	-	-	-	-	-	-	-
Other Income ⓘ +	0.11	0.23	0.06	0.04	0.07	0.02	0.03	0.05	2	0.18
Exceptional Items ⓘ	-0.03	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0.01	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0.02	-0	-0.03	-0.04	-0.05	-0.04	-0.01	1.88	0.08
Tax ⓘ	0	0.01	0	0	0	-0	0	-0	0.34	0.02
Profit After Tax	0	0.02	-0	-0.03	-0.04	-0.05	-0.04	-0.01	1.54	0.06
PAT Margin (%)	-	-	-	-	-	-	-	-	-	-
Adjusted EPS (₹)	0.0	0.2	-0.0	-0.3	-0.4	-0.5	-0.4	-0.1	8.0	0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1.79	2.52	2.75	2.83	2.25	3.22	3.72	3.49	10.83	11.78
Share Capital ⓘ	1.04	1.04	1.04	1.04	1.04	1.04	1.04	1.04	1.92	1.92
Reserves ⓘ	0.75	1.48	1.71	1.79	1.21	2.18	2.68	2.45	8.92	9.86
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	0.06	0.18	0.26	0.28	0.15	0.48	0.65	0.57	0.69	0.84
Total Liabilities ⓘ	1.85	2.70	3	3.11	2.40	3.70	4.37	4.06	11.53	12.62
Fixed Assets
Net Fixed Assets ⓘ +	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0	0
Gross Block	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Accumulated Depreciation	0.02	0.03	0.03	0.04	0.04	0.04	0.04	0.05	0.05	0.05
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	1.74	2.61	2.96	3.07	2.35	3.67	4.35	4.04	2.93	12.47
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0.01	0.01	0	0	-0	0	0	0	0	0
Cash Equivalents	0.05	0.05	0.03	0.03	0.01	0.02	0.01	0.02	8.43	-0.02
Others Assets ⓘ	0.03	0	0	0	0.03	0	0	0	0.16	0.16
Total Assets ⓘ	1.85	2.70	3	3.11	2.40	3.70	4.37	4.06	11.53	12.62

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.01	0	0.05	-0.56	1.28	0.61	-0.35	-1.34	0.30
PBT ⓘ	0	0.02	-0.03	-0.04	-0.05	-0.04	-0.01	1.88	0.08
Adjustment ⓘ	-0.03	-0.02	0.08	-0.48	1.30	0.65	-0.34	-3.11	-0.64
Changes in Working Capital ⓘ	0.02	0	-0	-0.04	0.03	-0	-0	0.24	0.54
Tax Paid ⓘ	0	-0	0	0	0	0	0	-0.34	0.32
Cash Flow From Investing Activity ⓘ +	0.05	0	-0.05	0.54	-1.27	-0.62	0.36	3.63	-9.30
Capex	0	-0.01	0	0	0	0	0	0	0
Net Investments	0.01	-0.02	-0.09	0.51	-1.29	-0.64	0.32	1.63	-9.48
Others ⓘ	0.04	0.02	0.04	0.03	0.02	0.03	0.03	2	0.18
Cash Flow From Financing Activity ⓘ +	0	0	0	0	0	0	0	6.13	0.55
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0.88	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	5.25	0.55
Net Cash Flow ⓘ	0.04	0	-0	-0.01	0.01	-0.01	0.01	8.42	-8.45

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.25	0.78	-0.16	-1.02	-1.48	-1.76	-1.09	-0.2	21.44	0.53
ROCE (%)	0.28	1.04	-0.13	-1	-1.48	-1.76	-1.09	-0.2	26.18	0.67
Asset Turnover Ratio	0	0	0	0	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	0	N/A	N/A	N/A	N/A	N/A	N/A	-0.87	5
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Skybiotech Healthcare Ltd FAQs

The current trading price of Skybiotech Healthcar on 17-Apr-2026 16:59 is ₹138.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Skybiotech Healthcar stood at ₹26.60 Cr

The latest P/E ratio of Skybiotech Healthcar as of 16-Apr-2026 is 0.00.

The latest P/B ratio of Skybiotech Healthcar as of 16-Apr-2026 is 2.28.

The 52-week high of Skybiotech Healthcar is ₹237.3 and the 52-week low is ₹116.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Skybiotech Healthcar is ₹0.00 ( Cr.) .

About Skybiotech Healthcare Ltd

Kapil Cotex Ltd is a Public Limited company incorporated on October 17, 1983. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai.

Business area of the company

The company is engaged in the business of textile & its allied products. It also deals in shares & Securities, where it earned capital gains & dividend income. Further, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Skybiotech Healthcare Ltd (512036) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Skybiotech Healthcar Share Price